School of Medicine
Showing 701-800 of 1,234 Results
-
Brittany Elizabeth Matheson, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical associate professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Ryan Matlow
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRyan Matlow, Ph.D., is a child clinical psychologist who serves as Director of Community Programs for Stanford’s Early Life Stress and Resilience Program, and is a faculty member in Stanford's Human Rights and Trauma Mental Health Program. His clinical and research efforts focus on understanding and addressing the impact of stress, adversity, and trauma in children, families, and communities. In particular, Dr. Matlow seeks to apply current scientific knowledge of the neurobiological and developmental impact of stress, trauma, and adversity in shaping interventions and systems of care. Dr. Matlow is focused on engaging diverse populations and providing evidence-based individual, family, and systems interventions for posttraumatic stress following interpersonal trauma, with an emphasis on efforts in school, community, and integrated care settings. He is engaged in clinical service, program development, and interdisciplinary collaboration efforts that address childhood trauma exposure in communities that have been historically marginalized, under-resourced, and/or experienced human rights violations. He has worked extensively in providing trauma-focused psychological evaluation, treatment, and advocacy services with immigrant youth and families, with a focus on immigrants from Latin American countries. Dr. Matlow is involved in the training and dissemination of Stanford's Cue Centered Therapy (Carrion, 2015), a flexible, manualized intervention addressing childhood experiences of chronic trauma.
-
Mohamad Matout, MD, MSc
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mohamad Matout is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Matout specializes in using brain stimulation therapies to treat mental illnesses and neurological disorders that do not respond to standard treatments. These therapies include deep brain stimulation (DBS), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). He serves as the attending psychiatrist for the Youth TMS Clinic at Stanford Health Care, providing transcranial magnetic stimulation for adolescents with treatment-resistant mood disorders. Dr. Matout also uses avatar therapy, an investigational treatment for psychosis that involves using a digital avatar to represent the voices a patient hears.
Dr. Matout’s research centers on brain health as a unifying framework for understanding psychiatric illness across the lifespan. Using a statistical modeling technique called psychometric network analysis, he maps how psychiatric symptoms mutually reinforce or suppress one another. This method reveals the structure of mental illness beyond traditional diagnostic categories. Dr. Matout developed the approach through his graduate work on brain health in HIV and post-COVID syndrome. He now applies it to neuromodulation (changing nerve signals for treatment) and other novel interventions.
Dr. Matout’s two primary lines of research are TMS for adolescents and avatar therapy. He also contributes to a broader range of neuromodulation studies through collaboration with the Brain Stimulation Lab at Stanford University School of Medicine. Beyond his clinical and research work, Dr. Matout is co-founder of AVAtalk Technologies Inc., a mental health technology startup focused on avatar-based therapeutic solutions.
Dr. Matout has authored peer-reviewed publications in Social Psychiatry and Psychiatric Epidemiology, Quality of Life Research, and CEN Case Reports. He has also contributed chapters to Current Medical Diagnosis & Treatment 2027 and Katzung & Trevor's Basic & Clinical Pharmacology (17th ed., McGraw-Hill, in press).
Dr. Matout is a member of the American Neuropsychiatric Association (ANPA) and the Brain Stimulation Society (BraSS), where he serves as assistant treasurer. -
LAWRENCE McGLYNN
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMethamphetamine Abuse
HIV Neuropsychiatry -
Mark McGovern
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Pediatrics
BioDr. Mark McGovern is a Professor and the Associate Chair of Translation and Implementation Research in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.
Most people who need health care do not receive it. And of those who do, wide variation exists in access to care and the quality of the care they receive in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of implementation science to close these gaps in health care delivery.
His mission is to get the best health care possible to the people who need it the most.
Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Stanford Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national implementation research and practice centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he addresses implementation challenges in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing implementation science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide. -
Carmen McLean
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioCarmen McLean, PhD, is a clinical psychologist and researcher with the Dissemination and Training Division of the National Center for PTSD at the Palo Alto VA Health Care System. Dr. McLean’s research focuses on increasing the implementation and reach of evidence-based treatments for posttraumatic stress disorder (PTSD).
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Mitchell Miglis, MD
Clinical Professor, Adult Neurology
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Colleen Mills-Finnerty
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Mills-Finnerty received her PhD in Psychology from Rutgers University, with a focus on cognitive neuroscience. She completed a MIRECC Advanced Fellowship at the Palo Alto VA and Stanford Dept. Psychiatry and Behavioral Sciences, studying mood disorders using neuroimaging and neurostimulation. She was then awarded a VA Career Development Award to study attention and reward function in mood disorders. She joined the Women’s Operational Military Exposures Network as a Research Scientist in 2024. She is interested in health disparities that impact neurological and mental health in women Veterans, and their relationship to Military Environmental Exposures.
She has authored multiple award-winning papers, including “Affective Neuroscience: Applications for Sexual Medicine Research and Clinical Practice,” proposing a novel treatment schema for sexual trauma based on affective neuroscience, which was awarded the Bronze Prize for Best Paper by the International Society for Sexual Medicine. -
Christina Maria Miranda
Resident in Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioI am a Medical Degree candidate at Stanford University. I am originally from Milford, New Jersey. In 2021, I graduated with a bachelors degree in Neuroscience from the University of Pennsylvania. I am interested in pursuing a career in eating disorder treatment and research. I am also the co-founder and CEO of a Philadelphia-based 501(c)(3) nonprofit organization called Body Empowerment Project. We deliver educational workshops related to body image and self-esteem to Philadelphia public school students using a near-peer mentorship model and a validated body-positive curriculum.
-
Percy Khushroo Mistry
Social Science Research Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Scholar, Stanford Cognitive and Systems Neuroscience Laboratory
-
Amrita Mitchell-Krishnan, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Amrita Krishnan received her PhD in Counseling Psychology at New York University. She completed her residency training at Denver Health and fellowship training at CHOC children’s with an emphasis on pediatric psychology.
Dr. Krishnan provides clinical services within the Medical Coping and Wellness Clinic in Child Psychiatry. Additionally, she is an attending psychologist with the pediatric liver transplant team. -
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Hylton Molzof, PhD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Molzof is a Clinical Assistant Professor and Licensed Psychologist in the Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine. She specializes in the assessment and treatment of sleep disorders via behavioral sleep medicine interventions, including Cognitive Behavioral Therapy for Insomnia (CBT-I) and positive airway pressure (PAP) desensitization. She also utilizes evidence-based techniques to help patients better manage circadian rhythm disorders, such as delayed sleep-wake phase disorder and shift work sleep disorder. Inspired by her background in public health, she has a strong interest in quality improvement and program development projects aimed at enhancing the quality and accessibility of sleep and circadian medicine for the diverse patient population served by Stanford Sleep Medicine Center.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Rudolf Moos
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsOur research group works primarily on psychiatric program evaluation and the quality of health care. The studies focus heavily on health care programs and the context, process, outcome, and cost of care.
-
Kelli Moran-Miller, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Kelli Moran-Miller joined Stanford in Psychiatry & Behavioral Sciences in 2015. She is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She also is a Certified Mental Performance Consultant with the Association of Applied Sport Psychology and a member of the US Olympic Committee registry. In her current role with Stanford Athletics (DAPER), she provides clinical and performance psychology services for varsity student-athletes, coaches, staff, and varsity sport teams. Prior to Stanford, she was the Director of Counseling and Sport Psychology - Athletics at the University of Iowa.
-
Philippe Mourrain
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
On Partial Leave from 2026-09-01 To 2027-02-28BioExpertise: Neurobiology, Sleep sciences, Molecular Genetics, Developmental Biology, Gene Silencing/Epigenetics
Methodology: Synapse Imaging (Two photon microscopy, Array Tomography), Calcium Imaging (Light Sheet Microscopy/SPIM, Light Field Microscopy), Optogenetics, CLARITY, Tol2 transgenesis, TALENs, CRISPR/Cas9, Video tracking and behavior computation. -
Pavithra Mukunda
Clinical Rsch Mgr 1, Psych/Public Mental Health & Population Sciences
Current Role at StanfordClinical Research Manager
-
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association. -
Greer Murphy M.D., Ph.D.
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult), Emeritus
Current Research and Scholarly InterestsPharmacogenetics of mood disorders and nicotine addiction. Microglial neurotoxicity and neuroprotection in Alzheimer's disease. Genome wide expression analysis of mouse models for Alzheimer's disease.
-
Diana Naranjo
Clinical Professor, Pediatrics - Endocrinology
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child DevelopmentBioAs a licensed clinical psychologist working in diabetes and Cystic Fibrosis clinics for the past 10 years, Dr. Naranjo focuses on the psychosocial needs of patients and families with diabetes and CF. Through clinical research, she aims to understand barriers and facilitators to diabetes self-management, how families and individuals with diabetes respond to health technology, and how to best provide services that engage youth and their families. She is a member of the Stanford Diabetes Research Center.
-
Trishna Narula, MD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Trishna Narula is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University, where she provides psychiatric care across inpatient, emergency, and outpatient settings and teaches and supervises medical students and residents. She serves patients through Stanford’s Women’s Wellness Clinic, Adult ADHD Assessment Clinic, and Centerspace Clinic, where she is the founding and leading psychiatrist of Stanford’s innovative clinical program focused on South Asian mental health. She also provides psychiatric care to a diverse Medicaid population through Momentum for Health, a nonprofit community mental health organization. Dr. Narula’s clinical practice integrates evidence-based psychopharmacology with psychodynamic psychotherapy, for which she has completed additional advanced training. Her professional interests also include public health, mental health policy, and advocacy, and she currently serves as a Councilor for the Northern California Psychiatric Society (NCPS).
-
Kalpana Isabel Nathan
Adjunct Clinical Professor, Psychiatry and Behavioral Sciences
BioKalpana Nathan, MD is an adjunct clinical professor, Psychiatry and Behavioral Sciences at the Stanford University School of Medicine. After completion of residency and research fellowship at Stanford, she served 4 years at the San Francisco General Hospital/UCSF, gaining experience in the areas of substance use, HIV and public health. She worked at Palo Alto VA for more than a couple of decades. She served as chief medical director at Mental Health and Addiction services, El Camino Health for two and a half years, and later was the Executive Medical Director of Custody Behavioral Health at Santa Clara County. She is a certified physician executive. She has worked and taught in various settings, both inpatient and outpatient, as well as private and public sectors. She is board certified in General, Addiction and Forensic Psychiatry, as well as Lifestyle Medicine. Her interests include wellness and self-care for physicians, women's health, health creation and resiliency building for the community. She is a certified meditation teacher, has completed sprint and Olympic triathlons, and enjoys traveling around the world. She received the outstanding community clerkship preceptor award in 2010 and the Arthur L. Bloomfield Award in Recognition of Excellence in the Teaching of Clinical Medicine in 2015 at the Stanford University School of Medicine.
Recent Publications:
1. Yen Li, M, Mata C, Nathan K: Is Life Unlivable for Youth in Post-DEI America?: Understanding Rising Suicide Rates Across Diverse Youth Groups Through Traditional Suicide Paradigms. Healthcare 2025 Oct, 13(20), 2585 https://doi.org/10.3390/healthcare13202585
2. Tran BX, Nguyen TT, Boyer L, Fond G, Auquier P, Nguyen HSI,Ha Thi Nhi Tran HTN, Nguyen HM, Choi J, Le HT, Latkin CA, Nathan KI, Husain SF, et al: Differentiating people with schizophrenia from healthy controls in a developing country: An evaluation of portable functional near infrared spectroscopy (fNIRS) as an adjunct diagnostic tool. Frontiers of Psychiatry 2023 Jan 26; vol 14
3. Tatum, J, Nathan, K: The USA. Lancet Psychiatry 2021, 8(5):365-366
4. Nathan N & Nathan KI: Suicide, Stigma, and Utilizing Social Media Platforms to Gauge Public Perceptions. Front. Psychiatry 2020 January 13
5. Tran BX, Nathan KI, Phan HT, Hall BJ, Vu GT et al: A Global Bibliometric Analysis of Services for Children Affected by HIV/Acquired Immune Deficiency Syndrome: Implications for Impact Mitigation Programs (GAPRESEARCH). AIDS Rev. 2019 Oct 3;21(3).
6.Lee A, Nathan KI: Understanding Psychosis in a Veteran With a History of Combat and Multiple Sclerosis. Fed Pract. 2019 Jun;36(Suppl 4):S32-S35.
7. Tran BX, Ha GH, Vu GT, Nguyen LH, Latkin CA, Nathan K, McIntyre RS, Ho CS, Tam WW, Ho RC: Indices of Change, Expectations, and Popularity of Biological Treatments for Major Depressive Disorder between 1988 and 2017: A Scientometric Analysis. Int J Environ Res Public Health. 2019 Jun 26;16(13) -
Shaghayegh Navabpour
Postdoctoral Scholar, Psychiatry
Current Research and Scholarly InterestsMy research investigates how genetic, transcriptomic, and epigenomic mechanisms shape brain function and contribute to psychiatric disorders, with a special focus on PTSD. By combining large-scale human genomic data with molecular neuroscience approaches, I aim to identify cell-type-specific pathways and therapeutic targets that advance our understanding and treatment of mental health conditions.
-
Gregory M. Nikogosyan, DO, MBA
Fellow in Psychiatry and Behavioral Sciences
BioDr. Nikogosyan is currently the Interventional Psychiatry Fellow at Stanford University School of Medicine. He has prior experience and fellowship training in Brain Injury Medicine and Consultation-Liaison Psychiatry. His clinical work and interests include circuit-based understanding of the illness with focus on diagnosis, biomarkers, and treatment modalities. Prior to his fellowships he served as Assistant Professor of Psychiatry at University of New Mexico School of Medicine where he developed initial interests in interventional psychiatry providing accelerated transcranial magnetic stimulation treatments and further through working in the neuropsychiatry clinic developing further his understanding of the brain through care for complex psychiatric presentations stemming from neurological disorders.
-
Seigo Ninomiya
Clinical Research Coordinator Associate, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioAt Stanford University School of Medicine, Seigo worked in NIH funded Clinical trials for a variety of neuropsychiatric disorder, and hands-on experience dealing data from neuroimaging methods such as fMRI, EEG, and 3D Neuro-navigation system. At UCSF School of Medicine, he has completed the internship program with the Center for Intelligent Imaging. As a part of Biomagnetic Imaging Lab and Speech Neuroscience Lab at UCSF School of Medicine, He has done data processing, Data QC, and analysis of MEG, fMRI data and several neuropsych scales such as GAD7, YBOCS, and Tinnitus Functional Index. He have hands-on experience on advanced neuroimaging technologies including fMRI and EEG in laboratory settings at University of California Davis., and obtained a CITI training certificate in both biological/behavioral training, and MRI training certificate from UC Davis Imaging Research center.
-
Seiji Nishino
Professor (Research) of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsThe research focus of the Sleep and Circadian Neurobiology (SCN) Laboratory is the study of the sleep and circadian physiology using various animal models. A portion of the research is carried out using rodent models of narcolepsy and circadian rhythm sleep disorders. The laboratory also carries out pharmacological studies aiming to develop new treatments for these sleep disorders.
-
Douglas Noordsy
Clinical Professor, Psychiatry and Behavioral Sciences
BioDouglas L. Noordsy, MD, is Clinical Professor, Director of Lifestyle Psychiatry and co-founder of the Sports Psychology & Psychiatry clinic in the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. Dr. Noordsy was previously Professor of Psychiatry at the Geisel School of Medicine at Dartmouth. His research interests include effects of physical exercise on neurotrophic factors, brain volume and function and mental health and wellbeing. He is particularly interested in the role of physical exercise for prevention of progression of early psychosis and interactions between social and physical aspects of team sports. Dr. Noordsy is a member of the American College of Psychiatry, American College of Lifestyle Medicine and is a Distinguished Fellow of the American Psychiatric Association. He is a member of the editorial boards for Community Mental Health Journal and Mental Health & Physical Activity. Dr. Noordsy was recognized with the Exemplary Psychiatrist Award from the National Alliance on Mental Illness in 2001, and the Excellence in Leadership Award from the Department of Psychiatry & Behavioral Sciences at Stanford in 2018. He launched the Stanford Lifestyle & Sports Psychiatry Special Initiative of the Department of Psychiatry in 2024 and is seeking philanthropic partners.
https://med.stanford.edu/psychiatry/special-initiatives/lifestyle.html
https://med.stanford.edu/psychiatry/patient_care/lifestyle.html -
Cynthia Nyongesa
Postdoctoral Scholar, Psychiatry
BioCynthia graduated from the University of California San Diego in 2026 with a Ph.D. in Computational Neurosciences. Her dissertation focused on multimodal digital biomarkers, using speech, virtual reality, and eye-tracking to detect Alzheimer's disease years before symptoms emerge. Growing up in Nairobi, Kenya, Cynthia developed an early passion for accessible healthcare, particularly for communities with limited access to advanced diagnostics. She is now a Postdoctoral Fellow in Dr. Ehsan Adeli's STAI Lab at Stanford, supported by the PRISM Baker Fellowship, where she is extending her work on passive biomarkers to gait, mobility, and neuroimaging.
-
Ruth O'Hara
Director, Spectrum, Senior Associate Dean, Research and Lowell W. and Josephine Q. Berry Professor
Current Research and Scholarly InterestsDr. O'Hara's research aims to investigate how cognitive information processing deficits subserve affective symptoms in psychiatric disorders, and interact with key brain networks integral to these disorders. To do so, she has implemented a translational, interdisciplinary program that encompasses cellular models, brain and behavioral assays of affective and cognitive information processing systems in psychiatric disorders across the lifespan.
-
Conner Oberhauser
Clinical Research Coordinator Associate, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
BioEmpathetic and driven aspiring physician with a B.S. in Biology (Neurobiology), a minor in Psychology, and Honors in Science, Technology, and Society from Stanford University. Currently working as a Clinical Research Coordinator Associate at Stanford's School of Medicine, supporting precision psychiatry research within the Department of Psychiatry and Behavioral Sciences. I bring experience in both qualitative and quantitative research focused on mental health, health disparities, and chronic illness. Skilled in patient-centered communication, interdisciplinary collaboration, community engagement, and data analysis. Deeply committed to mental health advocacy, suicide prevention, and advancing equitable, personalized care. Ultimately pursuing a career in medicine grounded in compassion, innovation, and social impact.
-
Maurice M. Ohayon, MD, DSc, PhD
Professor of Psychiatry and Behavioral Sciences (Sleep Medicine)
Current Research and Scholarly InterestsMy research focuses on population-based sleep and mental health epidemiology, including insomnia, hypersomnolence, narcolepsy, idiopathic hypersomnia, depression, anxiety, PTSD, and pain. I also develop and apply AI-assisted structured diagnostic interviews, including Sleep-EVAL/Ad-Infer, to improve phenotyping, differential diagnosis, longitudinal follow-up, and the study of comorbidity in large populations.
-
Alisa Marie Olmsted
Clinical Assistant Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioI am a board-certified psychiatrist specializing in interventional treatments for mood disorders, including transcranial magnetic stimulation (TMS), esketamine, and intravenous ketamine. I completed an Advanced MD Fellowship at the Sierra Pacific Mental Illness Research, Education, and Clinical Center (MIRECC), a Veterans Affairs (VA) Center of Excellence at VA Palo Alto, where my work focused on circuit-based approaches to precision psychiatry. I completed residency at Jefferson University Hospital, where I served as research chief and served on the ethics board, gaining broad clinical experience across inpatient, emergency, consultation-liaison, and addiction psychiatry. My research on Veterans has been published in Nature Mental Health and the Journal of Affective Disorders Reports, while my earlier clinical work was cited in The New York Times. I have provided continuous care to Veterans since medical school, including at the Hunter Holmes VA, where I earned honors, and at the Wilmington VA community-based outpatient clinic (CBOC). My commitment to serving Veterans is informed by a family legacy that includes multiple generations of combat Veterans, a perspective that continues to shape my clinical and research priorities within the VA system.
-
Nichole Olson
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr. Nichole Olson is a Clinical Assistant Professor and licensed psychologist in the INSPIRE Clinic and Dialectical Behavior Therapy (DBT) program at Stanford. Dr. Olson completed her masters and doctorate degrees at Northwestern University in Chicago and finished her postdoctoral fellowship at Stanford University. Dr. Olson specializes in evidence-based, recovery-oriented care for individuals with psychosis, providing both individual and group Cognitive Behavioral Therapy for Psychosis (CBTp) to adults within the INSPIRE Clinic. In addition, Dr. Olson leads trainings and ongoing consultation for providers learning to implement CBTp. As a clinician and Assistant Director of Stanford’s DBT program, Dr. Olson also provides individual DBT treatment for those with emotion regulation difficulties.
